Imlygic 1000000 [PFU]/mL
talimogene laherparepvec · INJECTION, SUSPENSION · Amgen Inc
Imlygic is a injection, suspension containing talimogene laherparepvec at 1000000 [PFU]/mL, taken intralesional. Manufactured by Amgen Inc.
Key Facts
- Brand Name
- Imlygic
- Generic Name
- talimogene laherparepvec
- NDC Code (Product)
55513-078- Manufacturer
- Amgen Inc
- Strength
- 1000000 [PFU]/mL
- Dosage Form
- INJECTION, SUSPENSION
- Route
- INTRALESIONAL
- Marketing Status
- Application #
- BLA125518
- Marketing Start
- 11/02/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is Imlygic used for?
Imlygic contains talimogene laherparepvec. It is a injection, suspension taken intralesional. Consult your doctor for specific uses.
Is Imlygic a controlled substance?
Imlygic is not classified as a controlled substance by the DEA.
What is the generic name for Imlygic?
The generic name for Imlygic is talimogene laherparepvec. There are no other listed brand versions of talimogene laherparepvec.
What is the NDC code for Imlygic 1000000 [PFU]/mL?
The NDC (National Drug Code) for Imlygic 1000000 [PFU]/mL is 55513-078, listed by Amgen Inc.
Other Imlygic Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)